Eli Lilly, now the world’s largest healthcare company with a market cap of $823 billion, is using its success from GLP-1 drugs like Mounjaro and Zepbound to tackle major health issues. The company’s sales have surged nearly 60% since Mounjaro’s approval in 2022, and its stock price has soared 268% in three years. Lilly is now focusing on diseases like heart disease, hearing loss, addiction, chronic pain, Alzheimer’s, and ALS. They’re testing Kisunla, a drug that removes amyloid plaques from the brain, to prevent Alzheimer’s. The company is also investing heavily in gene therapy, opening a $700 million institute in Boston. Despite industry challenges in gene therapy delivery, Lilly believes it can overcome these hurdles.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
